The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development

Byeongwoo Park, Ki Suk Kim, Min Kyu Heo, Woo Ick Yang, Seung Il Kim, Joo Hang Kim, Gwi Eon Kim, Kyong Sik Lee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Backgound and Objectives: Although more than five variant forms of estrogen receptor-β (ERβ) have been identilied, their role has not been identified. This study was carried out to investigate the changes of ERβ variants in breast cancer development. Methods: Using reverse transcription polymerase chain reaction (RT-PCR) and triple primer PCR (TP-PCR), the expression levels of ERβ variants mRNA were measured in 66 paired normal and cancer tissues. The relative expression level of ERβ variants were compared between normal and cancer tissues, and also compared according to various clinicopathological parameters. Results: Among ERβ variants, ERβ2 and ERβ5 consist of the major proportion of ERβ expression both in normal and cancer tissues. The ERβ and ERβ2 expression levels decreased significantly in the cancers compared with corresponding normal tissues, particularly in ERα-expressing cancers. However, ERβ5 expression level increased significantly in the cancers, especially in those of postmenopausal patients. The relative increase of ERβ5 expression in cancer tissues was associated with favorable differentiation. Conclusions: Decrease of ERβ2 is thought to be the key reason for the decrease in ERβ expression in cancer tissues, and it is particularly associated with the development of ERα-expressing breast cancer.

Original languageEnglish
Pages (from-to)504-510
Number of pages7
JournalJournal of Surgical Oncology
Volume93
Issue number6
DOIs
Publication statusPublished - 2006 May 1

Fingerprint

Estrogen Receptor beta
Estrogen Receptors
Carcinogenesis
Breast
Breast Neoplasms
Neoplasms
Polymerase Chain Reaction
Reverse Transcription

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Park, Byeongwoo ; Kim, Ki Suk ; Heo, Min Kyu ; Yang, Woo Ick ; Kim, Seung Il ; Kim, Joo Hang ; Kim, Gwi Eon ; Lee, Kyong Sik. / The changes of estrogen receptor-β variants expression in breast carcinogenesis : Decrease of estrogen receptor-β2 expression is the key event in breast cancer development. In: Journal of Surgical Oncology. 2006 ; Vol. 93, No. 6. pp. 504-510.
@article{f8ce36df54f84319b5284cf425c23463,
title = "The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development",
abstract = "Backgound and Objectives: Although more than five variant forms of estrogen receptor-β (ERβ) have been identilied, their role has not been identified. This study was carried out to investigate the changes of ERβ variants in breast cancer development. Methods: Using reverse transcription polymerase chain reaction (RT-PCR) and triple primer PCR (TP-PCR), the expression levels of ERβ variants mRNA were measured in 66 paired normal and cancer tissues. The relative expression level of ERβ variants were compared between normal and cancer tissues, and also compared according to various clinicopathological parameters. Results: Among ERβ variants, ERβ2 and ERβ5 consist of the major proportion of ERβ expression both in normal and cancer tissues. The ERβ and ERβ2 expression levels decreased significantly in the cancers compared with corresponding normal tissues, particularly in ERα-expressing cancers. However, ERβ5 expression level increased significantly in the cancers, especially in those of postmenopausal patients. The relative increase of ERβ5 expression in cancer tissues was associated with favorable differentiation. Conclusions: Decrease of ERβ2 is thought to be the key reason for the decrease in ERβ expression in cancer tissues, and it is particularly associated with the development of ERα-expressing breast cancer.",
author = "Byeongwoo Park and Kim, {Ki Suk} and Heo, {Min Kyu} and Yang, {Woo Ick} and Kim, {Seung Il} and Kim, {Joo Hang} and Kim, {Gwi Eon} and Lee, {Kyong Sik}",
year = "2006",
month = "5",
day = "1",
doi = "10.1002/jso.20336",
language = "English",
volume = "93",
pages = "504--510",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "6",

}

The changes of estrogen receptor-β variants expression in breast carcinogenesis : Decrease of estrogen receptor-β2 expression is the key event in breast cancer development. / Park, Byeongwoo; Kim, Ki Suk; Heo, Min Kyu; Yang, Woo Ick; Kim, Seung Il; Kim, Joo Hang; Kim, Gwi Eon; Lee, Kyong Sik.

In: Journal of Surgical Oncology, Vol. 93, No. 6, 01.05.2006, p. 504-510.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The changes of estrogen receptor-β variants expression in breast carcinogenesis

T2 - Decrease of estrogen receptor-β2 expression is the key event in breast cancer development

AU - Park, Byeongwoo

AU - Kim, Ki Suk

AU - Heo, Min Kyu

AU - Yang, Woo Ick

AU - Kim, Seung Il

AU - Kim, Joo Hang

AU - Kim, Gwi Eon

AU - Lee, Kyong Sik

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Backgound and Objectives: Although more than five variant forms of estrogen receptor-β (ERβ) have been identilied, their role has not been identified. This study was carried out to investigate the changes of ERβ variants in breast cancer development. Methods: Using reverse transcription polymerase chain reaction (RT-PCR) and triple primer PCR (TP-PCR), the expression levels of ERβ variants mRNA were measured in 66 paired normal and cancer tissues. The relative expression level of ERβ variants were compared between normal and cancer tissues, and also compared according to various clinicopathological parameters. Results: Among ERβ variants, ERβ2 and ERβ5 consist of the major proportion of ERβ expression both in normal and cancer tissues. The ERβ and ERβ2 expression levels decreased significantly in the cancers compared with corresponding normal tissues, particularly in ERα-expressing cancers. However, ERβ5 expression level increased significantly in the cancers, especially in those of postmenopausal patients. The relative increase of ERβ5 expression in cancer tissues was associated with favorable differentiation. Conclusions: Decrease of ERβ2 is thought to be the key reason for the decrease in ERβ expression in cancer tissues, and it is particularly associated with the development of ERα-expressing breast cancer.

AB - Backgound and Objectives: Although more than five variant forms of estrogen receptor-β (ERβ) have been identilied, their role has not been identified. This study was carried out to investigate the changes of ERβ variants in breast cancer development. Methods: Using reverse transcription polymerase chain reaction (RT-PCR) and triple primer PCR (TP-PCR), the expression levels of ERβ variants mRNA were measured in 66 paired normal and cancer tissues. The relative expression level of ERβ variants were compared between normal and cancer tissues, and also compared according to various clinicopathological parameters. Results: Among ERβ variants, ERβ2 and ERβ5 consist of the major proportion of ERβ expression both in normal and cancer tissues. The ERβ and ERβ2 expression levels decreased significantly in the cancers compared with corresponding normal tissues, particularly in ERα-expressing cancers. However, ERβ5 expression level increased significantly in the cancers, especially in those of postmenopausal patients. The relative increase of ERβ5 expression in cancer tissues was associated with favorable differentiation. Conclusions: Decrease of ERβ2 is thought to be the key reason for the decrease in ERβ expression in cancer tissues, and it is particularly associated with the development of ERα-expressing breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=33646838418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646838418&partnerID=8YFLogxK

U2 - 10.1002/jso.20336

DO - 10.1002/jso.20336

M3 - Article

C2 - 16615154

AN - SCOPUS:33646838418

VL - 93

SP - 504

EP - 510

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 6

ER -